top of page

Home > Specialists > Urology > Dr. Yu Zhu (朱煜)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Kidney cancer and urologic oncology specialist in Shanghai at Fudan University Shanghai Cancer Center, with a clinical focus on precision surgery for complex renal tumors, upper tract urothelial carcinoma, adrenal and retroperitoneal tumors, and minimally invasive robot-assisted and laparoscopic procedures.

Professional Title & Qualifications:

  • Associate Chief Physician

  • Associate Professor

  • Associate Researcher

  • M.D., Ph.D.

Hospital & Department:

Fudan University Shanghai Cancer Center – Department of Urology

(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)

Dr. Yu Zhu (朱煜) - Urology Specialist

Personal Biography

Dr. Yu Zhu is an Associate Chief Physician, Associate Professor, and Associate Researcher in the Department of Urology at Fudan University Shanghai Cancer Center. He holds an M.D. and Ph.D. from Fudan University Shanghai Medical College and leads the Kidney and Retroperitoneal Tumor Sub-specialty Team. His clinical work focuses on urological and male genital malignancies, particularly kidney and retroperitoneal tumors, with an emphasis on minimally invasive surgery, organ preservation, and individualized treatment planning. Dr. Zhu performs over 400 kidney cancer surgeries annually and has extensive experience with complex renal tumors, including completely endophytic, hilar, giant, and solitary-kidney tumors. He is also involved in research on precision classification and personalized treatment of kidney cancer and urothelial carcinoma and has contributed to national clinical guideline development.

Why Consult Dr. Yu Zhu for your care?

Dr. Yu Zhu’s clinical focus is particularly relevant to patients seeking specialist review for complex kidney or retroperitoneal tumors. At Fudan University Shanghai Cancer Center, he specializes in robot-assisted and laparoscopic nephron-sparing surgery, including technically challenging renal tumors where preservation of healthy kidney tissue is an important surgical consideration.


Dr. Zhu performs over 400 kidney cancer surgeries annually and manages completely endophytic, hilar, giant, and solitary-kidney tumors, as well as advanced renal cell carcinoma requiring complex surgical management. His practice combines minimally invasive techniques, computer-assisted reconstruction, ischemia-protection strategies, and individualized surgical planning.


For international patients, a remote specialist review before travel can be particularly useful when medical records, imaging, previous treatment history, and a focused list of questions are prepared in advance. Dr. Zhu’s experience also spans focal therapies such as cryoablation and NanoKnife, systemic treatment pathways, and multidisciplinary care, helping patients obtain a clearer specialist perspective on potential next steps before deciding whether to travel to Shanghai.

Pre-Travel Case Review & Specialist Liaison

Before planning medical travel to Shanghai, international patients can request MedBridgeNZ coordination for a pre-travel specialist review with Dr. Yu Zhu. We help organize medical records, coordinate translation where needed, transfer client-authorized documents to the relevant hospital team, and manage appointment communication.


Once the remote review is arranged, Dr. Zhu or the relevant specialist team will review the submitted records, provide an opinion and recommendations on potential surgical or treatment pathways, and respond to the patient’s key questions. This gives patients a clearer specialist perspective and a practical basis for deciding whether to pursue in-person care in Shanghai before committing to international travel.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Yu Zhu

Areas of Expertise

  • Kidney Cancer Precision Surgery: Specializes in robot-assisted and laparoscopic nephron-sparing surgery (partial nephrectomy). He is an expert in managing complex renal tumors (completely endophytic, hilar, giant, and solitary kidney tumors) using computer reconstruction and ischemia protection strategies to maximize renal function preservation. He performs over 400 kidney cancer surgeries annually.

  • Advanced Kidney Cancer Management: Experienced in cytoreductive nephrectomy for giant renal cell carcinoma (RCC) and complex thrombectomy for RCC with inferior vena cava tumor thrombus. He also specializes in zero-ischemia laparoscopic tumor enucleation and focal therapies (cryoablation, RFA, NanoKnife).

  • Upper Tract Urothelial Carcinoma (UTUC): Expert in robot-assisted and laparoscopic radical nephroureterectomy with lymph node dissection, featuring a specialized single-position technique.

  • Adrenal & Retroperitoneal Tumors: Minimally invasive surgery for functional and non-functional adrenal tumors (pheochromocytoma, primary aldosteronism, etc.) and complex retroperitoneal sarcomas requiring multidisciplinary team (MDT) collaboration.

  • Comprehensive Medical Therapy: Personalized systemic therapy for advanced urological cancers, including targeted therapy, immunotherapy, chemotherapy, radiotherapy, and clinical trials for new drugs.

  • General Urological Oncology: Diagnosis and treatment of prostate cancer, bladder cancer, penile cancer, testicular cancer, and Extramammary Paget's disease.

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

* Treatment Pathway Satisfaction:

5.0/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

4,800 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • Associate Chief Physician & Associate Professor: Department of Urology, Fudan University Shanghai Cancer Center.

  • Group Leader: Kidney and Retroperitoneal Tumor Sub-specialty Team.

  • Assistant to the Director: Department of Surgery, Fudan University Shanghai Cancer Center.

  • Teaching Secretary: Department of Urology, Fudan University Shanghai Cancer Center.

  • Clinical Instructor & Examiner: Supervisor for standardized residency training and clinical skills training; Examiner for Shanghai standardized residency training and physician qualification exams.

Education & Training

  • M.D. and Ph.D., Fudan University Shanghai Medical College.

Awards & Honors

  • Shanghai Oriental Talent Program (Young Project): Formerly Shanghai Youth Top-notch Talent.

  • Shanghai "Medical Star" Young Medical Talent.

  • Excellent Young Scholar Fund: Fudan University Shanghai Cancer Center.

  • Top 10 Surgical Video Award: China Anti-Cancer Association (CACA-GU).

  • Third Prize: "Pujiang U-Star" Surgical Competition, Shanghai Medical Doctor Association Urology Branch.

  • First Prize: 3rd Health Science Popularization Short Video Competition, Fudan University Shanghai Medical College.

  • Excellent Graduate / Outstanding Student Cadre: Fudan University.

Academic & Professional Memberships

  • Member: Kidney Cancer Group, Urological and Male Genital Tumor Committee, China Anti-Cancer Association (CACA-GU).

  • Member: Fertility Preservation and Restoration Committee, China Association for Improving Birth Outcome and Child Development (CAIBOCD).

  • Member: Surgical Medicine Branch / Male Reproductive Medicine Branch, China Sexology Association (CSA).

  • Standing Committee Member: Urology Branch / Male Reproductive and Sexual Medicine Branch, Chinese Non-Government Medical Institutions Association (CNMIA).

  • Review Expert: National Natural Science Foundation of China (NSFC); Shanghai Municipal Science and Technology Commission.

  • Editorial Board Member: The Innovation, Holistic Integrative Oncology (HIO), AUO.

  • Guideline Panel Member: Contributed to guidelines including CACA-GU Kidney Cancer Guidelines, Kidney Tumor Diagnosis, Treatment and Rehabilitation Guidelines, and CSCO Clinical Guidelines for Immune Checkpoint Inhibitors.

Research & Publications

  • Research Focus: Precision typing and personalized treatment of kidney cancer and urothelial carcinoma.

  • Publications: Published 39 papers in authoritative international journals such as BMJ Oncology, Clinical Cancer Research, Journal for Immunotherapy of Cancer, European Journal of Cancer, British Journal of Cancer, International Journal of Cancer, and Nature Communications.

  • Projects: Principal Investigator for 16 projects, including grants from the National Natural Science Foundation of China (3 projects), Shanghai Municipal Science and Technology Commission, and Shanghai Municipal Health Commission.

Selected Peer-Reviewed Publications

  • Anwaier A, Che X, Zhu Y, et al. Construction and application of a three-dimensional vascular variation-based nephrometry scoring system for completely endophytic renal tumors. J Natl Cancer Cent. 2024;4(4):346–353. PMID: 39735442

  • Zhang H, Bai L, Zhu Y, et al. Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. Nat Commun. 2023;14(1):4274. PMID: 37460463

  • Fu Q, Xu L, Zhu Y, et al. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion. Eur Urol. 2019;75(5):752–763. PMID: 30293904

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

Is Dr. Yu Zhu the right specialist for my kidney tumor or related urologic condition?


Dr. Zhu’s clinical focus includes precision surgery for complex kidney tumors, including completely endophytic, hilar, giant, and solitary-kidney tumors, as well as adrenal and retroperitoneal tumors. If you are considering whether his expertise is relevant to your case, MedBridgeNZ can coordinate the preparation, translation, and client-authorized transfer of your medical records for a remote specialist review. Once the review is arranged, Dr. Zhu or the relevant specialist team will review the submitted records, comment on how the case relates to his clinical focus, provide relevant opinion and recommendations, and address the questions submitted with your case.


How can I request a remote specialist review with Dr. Yu Zhu before traveling to China?


International patients can request remote specialist-review coordination with Dr. Yu Zhu before deciding whether to travel to Shanghai. MedBridgeNZ coordinates medical-record organization, translation support where needed, client-authorized document transfer to Fudan University Shanghai Cancer Center, and appointment communication. Once the remote review is arranged, Dr. Zhu or the relevant specialist team will review the submitted materials and provide a specialist opinion and recommendations on potential next steps, together with responses to the patient’s key questions. This gives you a clearer basis for deciding whether to pursue an in-person pathway in China.


What support can MedBridgeNZ coordinate if I decide to travel to Shanghai for in-person care?


If you decide to pursue in-person care in Shanghai after the specialist review, MedBridgeNZ can coordinate the non-clinical parts of the journey. Support can include hospital appointment request coordination, medical invitation or visa-document coordination support, travel planning, translation coordination, and bilingual administrative assistance during hospital visits. We can also help keep communication organized between you and the relevant hospital team before departure, so the administrative and travel arrangements are prepared around the hospital pathway.

Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Hospital, specialist, diagnostic, treatment, and travel charges are third-party costs unless expressly stated in writing.

bottom of page